PATE can influence its function through various signaling pathways that converge on the process of phosphorylation. Forskolin, by directly stimulating adenylate cyclase, leads to an increase in cyclic AMP (cAMP) within the cell, which in turn activates protein kinase A (PKA). Once activated, PKA can phosphorylate PATE, altering its activity. Similarly, Isoproterenol and Epinephrine, both of which are beta-adrenergic agonists, engage with their respective receptors to activate adenylate cyclase. The subsequent rise in cAMP levels also leads to PKA activation and phosphorylation of PATE. Prostaglandin E2 (PGE2) operates through its own set of G-protein-coupled receptors to activate adenylate cyclase, further propagating the signaling cascade that activates PKA and leads to PATE phosphorylation. Cell-permeable analogs of cAMP, such as 8-Bromo-cAMP and Dibutyryl-cAMP, mimic the natural substance's ability to activate PKA, bypassing the receptor-mediated activation steps, and directly leading to PATE phosphorylation.
cAMP-dependent pathways, Ionomycin raises intracellular calcium levels, which can activate calmodulin-dependent kinase (CaMK). CaMK, in turn, has the capacity to phosphorylate PATE. Phorbol 12-myristate 13-acetate (PMA) takes a different approach by activating protein kinase C (PKC), which phosphorylates a variety of proteins and could include PATE as one of its substrates. Anisomycin, through the activation of stress-activated protein kinases such as JNK, can also lead to the phosphorylation and subsequent activation of PATE. Calyculin A indirectly maintains PATE in a phosphorylated state by inhibiting the action of protein phosphatases such as PP1 and PP2A, which otherwise serve to dephosphorylate proteins. H-89, although primarily a PKA inhibitor, can lead to the activation of PATE by disrupting feedback inhibition mechanisms that might result in a compensatory activation of PKA. Lastly, 1,9-Dideoxyforskolin, like forskolin, increases cAMP and activates PKA, consequently leading to the phosphorylation of PATE. Each of these chemicals, through their distinctive mechanisms, can modulate the activity state of PATE by influencing its phosphorylation status.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that binds to the beta-adrenergic receptor, leading to G-protein activation and subsequent activation of adenylate cyclase. The increase in cAMP levels results in activation of PKA, which can phosphorylate and activate PATE as part of the downstream signaling cascade. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with beta-adrenergic receptors to stimulate adenylate cyclase activity, increasing cAMP levels in the cell, which in turn activates PKA. PKA activation can result in the phosphorylation and activation of PATE. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) binds to its G-protein-coupled receptor (EP receptors), which can lead to adenylate cyclase activation and a rise in cAMP levels. This cAMP can activate PKA, leading to the phosphorylation and functional activation of PATE. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinase (CaMK), which may phosphorylate and activate PATE, as PATE's activity is known to be modulated by calcium-mediated signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) by directly binding to it. Activated PKC can phosphorylate various proteins, potentially including PATE, leading to its activation within the cell signaling pathways where PKC is upstream. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that resists degradation and activates PKA. Activated PKA can phosphorylate PATE, leading to its activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs) such as JNK. JNK signaling can lead to the phosphorylation of target proteins, which may include PATE, resulting in its activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is another cell-permeable analog of cAMP that activates PKA. Upon activation, PKA may phosphorylate PATE, which results in the activation of PATE's function in cells. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which can result in increased phosphorylation levels of proteins due to decreased dephosphorylation. This indirect effect may lead to the sustained activation of PATE through its phosphorylated state. | ||||||